Abstract:Objective: Articular chondrocyte activation, involving aberrant proliferation and prehypertrophic differentiation, is essential for osteoarthritis (OA) initiation and progression. Disruption of mechanistic target of rapamycin complex 1 (mTORC1) promotes chondrocyte autophagy and survival, and decreases the severity of experimental OA. However, the role of cartilage mTORC1 activation in OA initiation is unknown. In this study, we elucidated the specific role of mTORC1activation in OA initiation, andidentify the underlying mechanisms.Method: Expression of mTORC1 in articular cartilage of OA patients and OA mice was assessed by immunostaining. Cartilage-specific tuberous sclerosis complex 1 (Tsc1, mTORC1 upstream inhibitor) knockout (TSC1CKO) and inducible Tsc1 KO (TSC1CKO(ER)) mice were generated. The functional effects of mTORC1 in OA initiation and development on its downstream targets were examined by immunostaining, western blotting and qPCR.Results: Articular chondrocyte mTORC1 was activated in early-stage OA and in aged mice. TSC1CKO mice exhibited spontaneous OA, and TSC1CKO(ER) mice (from 2 months) exhibited accelerated age-related and DMM-induced OA phenotypes, with aberrant chondrocyte proliferation and hypertrophic differentiation. This was associated with hyperactivation of mTORC1 and dramatic downregulation of FGFR3 and PPR, two receptors critical for preventing chondrocyte proliferation and differentiation. Rapamycin treatment reversed these phenotypes in KO mice. Furthermore, in vitro rescue experiments demonstrated that p73 and ERK1/2 may mediate the negative regulation of FGFR3 and PPR by mTORC1.Conclusion: mTORC1 activation stimulates articular chondrocyte proliferation and differentiation to initiate OA, in part by downregulating FGFR3 and PPR. (C) 2017 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.

Mtorc1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, in Vitro and in Mice

mTORC1 Activation in Osteoclasts Prevents Bone Loss in a Mouse Model of Osteoporosis

Inactivation of Regulatory-associated Protein of Mtor (raptor)/mammalian Target of Rapamycin Complex 1 (mtorc1) Signaling in Osteoclasts Increases Bone Mass by Inhibiting Osteoclast Differentiation in Mice.

mTORC1 Prevents Preosteoblast Differentiation through the Notch Signaling Pathway

RhoA Promotes Osteoclastogenesis and Regulates Bone Remodeling Through Mtor-Nfatc1 Signaling.

Activation of mTORC1 in B Lymphocytes Promotes Osteoclast Formation via Regulation of β-Catenin and RANKL/OPG.

Osteocyte-intrinsic mTORC1 signaling restrains trabecular bone accrual in mice.

Inactivation of mTORC1 Signaling in Osterix-expressing Cells Impairs B-cell Differentiation.

Rictor/mTORC2 Loss in Osteoblasts Impairs Bone Mass and Strength.

The mTORC2 Component Rictor Is Required for Load-Induced Bone Formation in Late-Stage Skeletal Cells

Hyperactivation of Mtor Critically Regulates Abnormal Osteoclastogenesis in Neurofibromatosis Type 1

Activation of Mtorc1 in Subchondral Bone Preosteoblasts Promotes Osteoarthritis by Stimulating Bone Sclerosis and Secretion of CXCL12

TSC1 regulates osteoclast podosome organization and bone resorption through mTORC1 and Rac1/Cdc42

A RANKL-based Osteoclast Culture Assay of Mouse Bone Marrow to Investigate the Role of Mtorc1 in Osteoclast Formation.

Bone Size and Quality Regulation: Concerted Actions of mTOR in Mesenchymal Stromal Cells and Osteoclasts

Mammalian Target of Rapamycin Inhibitor Abrogates Abnormal Osteoclastogenesis in Neurofibromatosis Type 1

Dynamic control of mTORC1 facilitates bone healing in mice

mTORC1 regulates PTHrP to coordinate chondrocyte growth, proliferation and differentiation

Mtorc1 Activation Downregulates Fgfr3 and Pth/Pthrp Receptor in Articular Chondrocytes to Initiate Osteoarthritis

Biphasic Regulation of Osteoblast Development Via the ERK MAPK–mTOR Pathway

Pharmacological Inhibition of S6K1 Impairs Self‐renewal and Osteogenic Differentiation of Bone Marrow Stromal Cells